Pediatric Anthrax Clinical Management

This clinical report provides guidance on the prophylaxis and treatment of patients up to age 21 following an intentional anthrax release, with particular focus on areas where clinical recommendations for children differ from those for adults. The report discusses clinical presentations, post-exposure prophylaxis, infection control, management of patients with suspected and confirmed anthrax, and special considerations for breastfeeding infants.